Middle East & Africa Fish Vaccines Market Forecast to 2030

Middle East & Africa Fish Vaccines Market Forecast to 2030 – Regional Analysis – by Vaccine Type (Inactivated Vaccines, Live Attenuated Vaccines, Subunit Vaccines, Recombinant Vector Vaccine, and Others), Application (Bacterial Infection, Viral Infection, and Parasitic), Route of Administration (Injection Vaccine, Immersion Vaccine, and Oral Vaccine), and Species (Salmon, Trout, Tilapia, and Others)

Send Enquiry
Item ID: BMIRE00029705 Category: Tag:

$2,840$4,440

Description

The Middle East & Africa fish vaccines market was valued at US$ 17.54 million in 2022 and is expected to reach US$ 26.49 million by 2030; it is estimated to grow at a CAGR of 5.3% from 2022 to 2030.

Technological Advancements in Fish Vaccine Fuel the Middle East & Africa Fish Vaccines Market

Diversifying into new fish species, particularly marine fish, is a trend in the aquaculture sector. Farms across the world are increasingly relying on vaccinations to manage animal health. The development of novel pathogens with extensive antigenic diversity may also reduce the effectiveness of conventional vaccines. This motivates vaccine researchers to look into new techniques for creating potent vaccines for aquaculture. Subunit or recombinant DNA/RNA particle vaccines may have been created using modern vaccine technology, which is focused on specific pathogen components. Finding new vaccine candidates to fight fish pathogens such as mycotic and parasitic agents is made possible by recent advancements in vaccines and vaccinology. The development and production of fish vaccines can do rapidly with the help of new techniques in genetics, immunology, and biotechnology. These techniques include the use of genetically engineered vectors, recombinant vaccines, and DNA vaccines.

DNA vaccine technology provides significant protection against fish diseases. Targeting the construct and/or transgene to antigen-receptor cells is a promising way to improve the DNA vaccine’s effectiveness against other viral diseases. Molecular assemblies can be used to target dendritic cells (DC) and antigen-presenting cells (APC) in DNA vaccines, producing immune responses as a result. Another tactic is to encapsulate the DNA vaccine in specific carriers to increase transgene and MHC expression.

The development of novel vaccines known as recombinant DNA-based vaccine or new-generation vaccines has made extensive use of R DNA technology. Recombinant immunogenic protein vaccines or epitopes purified from vectors carrying the gene of interest produced in prokaryotic or eukaryotic expression systems, peptide vaccines, live vaccines produced by defined genetic manipulations, and microbial vectors carrying gene coding for immunogenic protein and DNA vaccines are among the types of vaccines based on recombinant DNA technology that have been developed. Recombinant vaccines have the advantage of closely simulating naturally occurring infections, which aids in triggering a potent immune response in the treated fish. They can also be mass produced easily.

Middle East & Africa Fish Vaccines Market Overview

The Middle East & Africa fish vaccines market has been segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. The market factors, such as rising consumption of seafood, growing government efforts, and rising infectious diseases among aquatic animals, are expected to boost the growth of fish vaccines over the forecast period. The South African fish vaccine market is mainly driven by the increasing production volume of aquaculture in the country. As per the data provided by the World Bank, aquaculture production in South Africa was 9,753 tonnes in 2020, and it increased to 10,525 tonnes in 2021. In South Africa, the sector is dominated by abalone, trout, and mussel, acting as a supplement to the fishing sector. Good infrastructure, business institutions, supply chains, and a supportive aquaculture legislation framework are responsible for the demand for aquaculture in the country. As the aquaculture industry grows, the production of healthy fish also increases, which, in turn, fuels the growth of the fish vaccines market.

Middle East & Africa Fish Vaccines Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Fish Vaccines Market Segmentation

The Middle East & Africa fish vaccines market is segmented based on vaccine type, application, route of administration, species, and country.

Based on vaccine type, the Middle East & Africa fish vaccines market is segmented into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held the largest market share in 2022.

Based on application, the Middle East & Africa fish vaccines market is segmented into bacterial infection, viral infection, and parasitic. The bacterial infection segment held the largest market share in 2022.

Based on route of administration, the Middle East & Africa fish vaccines market is segmented into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held the largest market share in 2022.

Based on species, the Middle East & Africa fish vaccines market is segmented into salmon, trout, tilapia, and others. The salmon segment held the largest market share in 2022.

Based on country, the Middle East & Africa fish vaccines market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The Rest of Middle East & Africa dominated the Middle East & Africa fish vaccines market share in 2022.

Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc. are some of the leading companies operating in the Middle East & Africa fish vaccines market.

Summary Info

Industry:

Pricing options:

, ,

Geographical coverage:

,

Year of Publication:

At 5.3% CAGR, the Middle East & Africa Fish Vaccines Market is Speculated to be worth US$ 26.49 million by 2030, says the Research Team

According to the Research Team’ research, the Middle East & Africa fish vaccines market was valued at US$ 17.54 million in 2022 and is expected to reach US$ 26.49 million by 2030, registering a CAGR of 5.3% from 2022 to 2030. Government initiatives to develop aquaculture industry and surging demand for aquatic animal-derived food products are the critical factors attributed to the Middle East & Africa fish vaccines market expansion.

Aquaculture grows exponentially due to the high demand for seafood and decreasing annual catch of wild fish. Thus, governments are taking initiatives to improve and support the growth of the aquacultural industry. Following are a few recent initiatives:

In February 2021, the Foundation for Food & Agriculture Research (FFAR) funded US$ 790,326 to create a delivery system for a vaccine that can help stop the tilapia lake virus and other diseases from spreading in the aquaculture sector. Saudi Arabia’s National Fisheries Development Programme seeks to attract over US$ 4 billion in domestic and foreign investment into the fishing industry as part of the Kingdom’s Vision 2030 goal to diversify the economy. In 2019, the 55-nation African Continental Free Trade Area (AfCFTA) came into effect. It has helped nations in the regions and benefitted them from free trade in seafood and fishery products and full compliance with the 1995 FAO Code of Conduct for Responsible Fisheries. Further, in 2020, to boost jobs and increase fish production, the Nigerian government has announced plans to build six new “fish farming estates” around Lagos. Other major initiatives have been observed in western African countries, including Ghana, Madagascar, Egypt, and Sierra Leone. Thus, an increase in government initiatives to support developments in the aquaculture industry drives the fish vaccine market growth.

On the contrary, stringent regulations for approval of vaccine hurdles the growth of Middle East & Africa fish vaccines market.

Based on vaccine type, the Middle East & Africa fish vaccines market is categorized into inactivated vaccines, live attenuated vaccines, subunit vaccines, recombinant vector vaccine, and others. The inactivated vaccines segment held 72.8% market share in 2022, amassing US$ 12.77 million. It is projected to garner US$ 19.37 million by 2030 to expand at 5.3% CAGR during 2022-2030.

Based on application, the Middle East & Africa fish vaccines market is categorized into bacterial infection, viral infection, and parasitic. The bacterial infection segment held 81.7% share of Middle East & Africa fish vaccines market in 2022, amassing US$ 14.33 million. It is projected to garner US$ 21.87 million by 2030 to expand at 5.4% CAGR during 2022-2030.

Based on route of administration, the Middle East & Africa fish vaccines market is categorized into injection vaccine, immersion vaccine, and oral vaccine. The injection vaccine segment held 59.4% share of Middle East & Africa fish vaccines market in 2022, amassing US$ 10.43 million. It is projected to garner US$ 15.66 million by 2030 to expand at 5.2% CAGR during 2022-2030.

Based on species, the Middle East & Africa fish vaccines market is categorized into salmon, trout, tilapia, and others. The salmon segment held 71.1% share of Middle East & Africa fish vaccines market in 2022, amassing US$ 12.47 million. It is projected to garner US$ 18.63 million by 2030 to expand at 5.1% CAGR during 2022-2030.

Based on country, the Middle East & Africa fish vaccines market has been categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 30.2% share of Middle East & Africa fish vaccines market in 2022. It was assessed at US$ 5.29 million in 2022 and is likely to hit US$ 8.40 million by 2030, exhibiting a CAGR of 5.9% during 2022-2030.

Key players operating in the Middle East & Africa fish vaccines market are Elanco Animal Health Inc, Hipra SA, Merck & Co Inc., Phibro Animal Health Corp, Vaxxinova International BV, and Zoetis Inc., among others.

– In Aug 2020, Elanco Closes Acquisition of Bayer Animal Health.

– In Mar 2020, HIPRA and Skretting combine expertise to tackle devasting trout disease.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa fish vaccines market.
o Highlights key business priorities in order to assist companies to realign their business strategies
o The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa fish vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
o Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the Middle East & Africa fish vaccines market, as well as those hindering it
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TABLE OF CONTENTS

1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Middle East & Africa Fish Vaccine Market
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Fish Vaccine Market – Key Industry Dynamics
4.1 Market Drivers:
4.1.1 Government Initiatives to Develop Aquaculture Industry
4.1.2 Surging Demand for Aquatic Animal-Derived Food Products
4.2 Market Restraints
4.2.1 Stringent Regulations for Approval of Vaccine
4.3 Market Opportunities
4.3.1 Development of Novel Fish Vaccine
4.4 Future Trends
4.4.1 Technological Advancements in Fish Vaccine
4.5 Impact Analysis:
5. Fish Vaccine Market – Middle East & Africa Market Analysis
5.1 Fish Vaccine Market Revenue (US$ Th), 2022 – 2030
6. Middle East & Africa Fish Vaccine Market – Revenue and Forecast to 2030 – by Vaccine Type
6.1 Overview
6.2 Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
6.3 Inactivated Vaccines
6.3.1 Overview
6.3.2 Inactivated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.4 Live Attenuated Vaccines
6.4.1 Overview
6.4.2 Live Attenuated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.5 Subunit Vaccines
6.5.1 Overview
6.5.2 Subunit Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.6 Recombinant Vector Vaccine
6.6.1 Overview
6.6.2 Recombinant Vector Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
6.7 Others
6.7.1 Overview
6.7.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7. Middle East & Africa Fish Vaccine Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
7.3 Bacterial Infection
7.3.1 Overview
7.3.2 Bacterial Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.4 Viral Infection
7.4.1 Overview
7.4.2 Viral Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
7.5 Parasitic
7.5.1 Overview
7.5.2 Parasitic: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8. Middle East & Africa Fish Vaccine Market – Revenue and Forecast to 2030 – by Route of Administration
8.1 Overview
8.2 Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
8.3 Injection vaccine
8.3.1 Overview
8.3.2 Injection vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.4 Immersion Vaccine
8.4.1 Overview
8.4.2 Immersion Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
8.5 Oral Vaccine
8.5.1 Overview
8.5.2 Oral Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9. Middle East & Africa Fish Vaccine Market – Revenue and Forecast to 2030 – by Species
9.1 Overview
9.2 Fish Vaccine Market Revenue Share, by Species, 2022 & 2030 (%)
9.3 Salmon
9.3.1 Overview
9.3.2 Salmon: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.4 Trout
9.4.1 Overview
9.4.2 Trout: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.5 Tilapia
9.5.1 Overview
9.5.2 Tilapia: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
9.6 Others
9.6.1 Overview
9.6.2 Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
10. Middle East & Africa Fish Vaccine Market – Country Analysis
10.1 Middle East & Africa Fish Vaccine Market, Revenue and Forecast to 2030
10.1.1 Overview
10.1.1.1 Middle East & Africa Fish Vaccine Market, by Country
10.1.1.2 Saudi Arabia
10.1.1.2.1 Overview
10.1.1.2.2 Saudi Arabia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.1.2.3 Saudi Arabia: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.1.2.4 Saudi Arabia: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.1.2.5 Saudi Arabia: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.1.2.6 Saudi Arabia: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.1.3 South Africa
10.1.1.3.1 Overview
10.1.1.3.2 South Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.1.3.3 South Africa: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.1.3.4 South Africa: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.1.3.5 South Africa: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.1.3.6 South Africa: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.1.4 UAE
10.1.1.4.1 Overview
10.1.1.4.2 UAE Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.1.4.3 UAE: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.1.4.4 UAE: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.1.4.5 UAE: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.1.4.6 UAE: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
10.1.1.5 Rest of Middle East Africa
10.1.1.5.1 Overview
10.1.1.5.2 Rest of Middle East Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
10.1.1.5.3 Rest of Middle East Africa: Fish Vaccine Market, by Vaccine Type, 2020-2030 (US$ Thousand)
10.1.1.5.4 Rest of Middle East Africa: Fish Vaccine Market, by Route of Administration, 2020-2030 (US$ Thousand)
10.1.1.5.5 Rest of Middle East Africa: Fish Vaccine Market, by Species, 2020-2030 (US$ Thousand)
10.1.1.5.6 Rest of Middle East Africa: Fish Vaccine Market, by Application, 2020-2030 (US$ Thousand)
11. Fish Vaccine Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in Fish Vaccine Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Zoetis Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck & Co Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 HIPRA SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Phibro Animal Health Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Vaxxinova International BV
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Elanco Animal Health Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Middle East & Africa Fish Vaccine Market Segmentation
Table 2. Worldwide Fish Production and Consumption in 2022
Table 3. Major Bacterial Diseases in Fish
Table 4. Major Viral Diseases in Fish
Table 5. Major Parasitic Diseases in Fish
Table 6. Atlantic Salmon Production 2020
Table 7. Saudi Arabia Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 8. Saudi Arabia Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 9. Saudi Arabia Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 10. Saudi Arabia Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 11. South Africa Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 12. South Africa Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 13. South Africa Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 14. South Africa Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 15. UAE Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 16. UAE Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 17. UAE Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 18. UAE Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 19. Rest of Middle East Africa Fish Vaccine Market, by Vaccine Type – Revenue and Forecast to 2030 (US$ Thousand)
Table 20. Rest of Middle East Africa Fish Vaccine Market, by Route of Administration – Revenue and Forecast to 2030 (US$ Thousand)
Table 21. Rest of Middle East Africa Fish Vaccine Market, by Species – Revenue and Forecast to 2030 (US$ Thousand)
Table 22. Rest of Middle East Africa Fish Vaccine Market, by Application – Revenue and Forecast to 2030 (US$ Thousand)
Table 23. Recent Inorganic Growth Strategies in the Fish Vaccine Market
Table 24. Recent Organic Growth Strategies in Fish Vaccine Market
Table 25. Glossary of Terms, Fish Vaccine Market

LIST OF FIGURES

Figure 1. Middle East & Africa Fish Vaccine Market Segmentation, By Country
Figure 2. Middle East & Africa Fish Vaccine Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Fish Vaccine Market Revenue (US$ Th), 2022 – 2030
Figure 5. Middle East & Africa Fish Vaccine Market Revenue Share, by Vaccine Type, 2022 & 2030 (%)
Figure 6. Inactivated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 7. Live Attenuated Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 8. Subunit Vaccines: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 9. Recombinant Vector Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 10. Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 11. Middle East & Africa Fish Vaccine Market Revenue Share, by Application, 2022 & 2030 (%)
Figure 12. Bacterial Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 13. Viral Infection: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 14. Parasitic: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 15. Middle East & Africa Fish Vaccine Market Revenue Share, by Route of Administration, 2022 & 2030 (%)
Figure 16. Injected: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 17. Immersion Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 18. Oral Vaccine: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 19. Fish Vaccine Market Revenue Share, Species, 2022 & 2030 (%)
Figure 20. Salmon: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 21. Trout: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 22. Tilapia: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 23. Others: Fish Vaccine Market – Revenue and Forecast to 2030 (US$ Thousand)
Figure 24. Middle East & Africa Fish Vaccine Market, by Key Country – Revenue, 2022 (US$ Thousand)
Figure 25. Middle East & Africa Fish Vaccine Market, By Key Countries, 2022 and 2030 (%)
Figure 26. Saudi Arabia Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 27. South Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 28. UAE Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 29. Rest of Middle East Africa Fish Vaccine Market Revenue and Forecast to 2030 (US$ Th)
Figure 30. Growth Strategies in Fish Vaccine Market

The List of Companies – Middle East & Africa Fish Vaccines Market

1. Elanco Animal Health Inc
2. Hipra SA
3. Merck & Co Inc.
4. Phibro Animal Health Corp
5. Vaxxinova International BV
6. Zoetis Inc.

Reviews

There are no reviews yet.

Be the first to review “Middle East & Africa Fish Vaccines Market Forecast to 2030”